CBD Kratom's Firm Stand Against Civil Investigative Demand from Missouri AG
CBD Kratom's Response to Civil Investigative Demand
On November 20, 2025, CBD Kratom officially acknowledged the Civil Investigative Demand (CID) issued by the Missouri Attorney General's Office. As a brand committed to consumer trust and safety, CBD Kratom has pledged full cooperation throughout the investigation. The company has emphasized the importance of demonstrating its stringent safety protocols and compliance measures, reinforcing the brand's long-standing dedication to consumer education.
CBD Kratom firmly states that it does not manufacture or sell products containing 7-hydroxymitragynine (7-OH), nor does it deal in synthetic derivatives of kratom. The company's business model is built on offering natural kratom products, underpinned by robust safety practices. This includes providing clear and accessible consumer information about how to utilize these products responsibly.
Commitment to Transparency and Compliance
Every product produced by CBD Kratom is subjected to rigorous testing for identity, potency, and purity—measures that are ingrained in their operational practices, not just mandated by law. The commitment to consumer safety is reflected in proper labeling, which includes explicit safety warnings and transparent product information. Moreover, CBD Kratom adheres to all local regulations and licensing requests across jurisdictions.
The company has consistently met and often gone beyond these legal standards. Notably, CBD Kratom supports the Kratom Consumer Protection Act (KCPA) and actively advocates for strong, sensible regulations. By providing scientific insights and supporting regulatory frameworks, the brand seeks to ensure that only safe and responsibly produced kratom products are available to consumers.
Expectations and Responsibilities
Despite their commitment, CBD Kratom has raised concerns regarding the broad scope of the CID, particularly considering they do not engage with 7-OH products. The brand stresses that clear distinctions between natural kratom and synthetic variants are vital in public health discussions. In this context, both the U.S. Department of Health and Human Services and the U.S. Food and Drug Administration have recognized this differentiation in their recent dialogues about naturally derived medicines.
CBD Kratom is prepared to deliver all requested information to the Attorney General promptly. They affirm that their operational model, characterized by rigorous testing, thorough labeling, and consumer education, aligns with regulatory expectations. Additionally, they remain committed to prioritizing natural ingredients and robust consumer guidance.
Innovative Product Initiatives
In line with its consumer trust initiatives, CBD Kratom is proud to promote innovative products such as DER—an unprecedented low-dose kratom beverage. This initiative, along with the company's ongoing emphasis on transparent labeling and consumer education, underscores their mission toward responsible and educated kratom use.
CBD Kratom is resolute in its commitment to cooperation and transparency, especially concerning the safety of Missouri's consumers. The brand looks forward to demonstrating how its rigorous testing, clear labeling, and informative consumer practices align with and often exceed standard regulatory measures. Through its actions, CBD Kratom continues to support the natural kratom leaf while emphasizing the need for differentiation from synthetic 7-OH derivatives.
About CBD Kratom
CBD Kratom stands as the largest privately owned retailer of CBD and kratom products in the United States, operating over 50 outlets across major cities including Chicago, Dallas, Houston, New York, Philadelphia, and St. Louis. Built on values of high-quality ingredients, transparent labeling, and accessible online ordering, CBD Kratom aims to provide a wide range of cannabis and kratom products to meet everyday wellness needs. The company is also recognized as the official CBD and kratom partner of the United Football League, setting the benchmark for responsible, consumer-focused industry practices.